为孕期戒烟量身定制的短信项目(MiQuit)的有效性与成本效果:随机对照试验(RCT)与Meta分析的研究方案
本研究为多中心平行组随机对照试验,计划在英国24家产前保健医院招募692名孕妇(每组346人),随机接受12周MiQuit定制互动短信自助戒烟支持或对照,并在随机化后4周及孕36周电话随访,最终与两项早期试验进行试验序贯分析Meta分析以评估疗效。
要点
- MiQuit为针对孕妇的12周定制互动短信自助戒烟支持项目。
- 计划纳入692名孕妇,随机化后4周及孕36周电话随访。
- 将与两项早期试验合并进行试验序贯分析Meta分析。
核心结论
- 本试验旨在完成MiQuit评估,证明其对孕期戒烟是否有效。
研究设计与样本
- 多中心、平行组随机对照试验,计划在英国24家产前保健医院招募692名孕妇(每组346人)。
- 纳入标准为年龄16岁以上、孕周小于25周、每日吸烟1支及以上但孕前每日至少吸烟5支、理解书面英语的孕妇。
- 参与者按1:1比例随机分组,按孕周(小于16周对16周及以上)分层。
- 所有参与者获得孕期戒烟宣传单并可获取英国国家医疗服务体系(NHS)标准戒烟支持;干预组额外接受12周MiQuit定制互动短信自助戒烟支持。
- 随机化后4周及孕36周进行电话随访。
主要发现
- 此前一项随机对照试验已证明MiQuit用于向吸烟孕妇发送短信自助支持是可行且可接受的。
- 另一项先导随机对照试验显示,在英国国家医疗服务体系(NHS)内开展更大规模多中心试验是可行的。
关键数值与推荐
- 样本量692例(每组346例)可使戒烟率差值的95%置信区间估计在±3%以内。
- 干预组戒烟率将与两项早期试验的戒烟率合并,通过试验序贯分析(TSA)Meta分析得出汇总疗效估计。
临床怎么用
- 若有效,MiQuit将成为帮助孕妇戒烟的廉价、成本效果好的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking in pregnancy is a major international public health problem. Self-help support (SHS) increases the likelihood of women stopping smoking in pregnancy and delivering this kind of support by text message could be a cost-effective way to deliver SHS to pregnant women who smoke. SHS delivered by text message helps non-pregnant smokers to stop but the currently available message programmes are not appropriate for use in pregnancy. A randomised controlled trial (RCT) has demonstrated the feasibility and acceptability of using a programme called 'MiQuit' to text SHS support to pregnant women who smoke. Another pilot RCT has shown that it would be feasible to run a larger, multi-centre trial within the UK National Health Service (NHS). The aim of this third RCT is to complete MiQuit's evaluation, demonstrating whether or not this is efficacious for smoking cessation in pregnancy. METHODS/DESIGN: This is a multi-centre, parallel-group RCT. Pregnant women aged over 16 years, of less than 25 weeks' gestation who smoke one or more daily cigarettes but smoked at least five daily cigarettes before pregnancy and who understand written English and are being identified in 24 English antenatal care hospitals. Participants are randomised to control or intervention groups in a 1:1 ratio stratified by gestation (< 16 weeks versus ≥ 16 weeks). All participants receive a leaflet on stopping smoking during pregnancy; they are also able to access standard NHS smoking cessation support. Intervention group women also receive the 12-week MiQuit programme of tailored, interactive text message, and self-help cessation support. Women are followed up by telephone at 4 weeks after randomisation and 36 weeks' gestation. The RCT will recruit 692 women (346 per group), enabling a 95% confidence interval for the difference in quit rates to be estimated within ± 3%. To determine whether or not MiQuit helps pregnant smokers to stop, intervention group quit rates from this trial will be combined with those from the two earlier trials in a Trial Sequential Analysis (TSA) meta-analysis to derive a pooled efficacy estimate. DISCUSSION: If effective, MiQuit will be a cheap, cost-effective method to help pregnant women to stop smoking. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03231553 . Registered on 20 July 2017.
引用
- Whitemore R, Leonardi-Bee J, Naughton F, et al. Effectiveness and cost-effectiveness of a tailored text-message programme (MiQuit) for smoking cessation in pregnancy: study protocol for a randomised controlled trial (RCT) and meta-analysis. Trials. 2019. PMID: 31118090. doi:10.1186/s13063-019-3341-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。